Three studies presented at the American Epilepsy Society's 69th Annual Meeting in Philadelphia highlight
emerging efficacy and safety data of Epidiolex, a pharmaceutical liquid formulation of cannabidiol, which is currently undergoing U.S. Food and Drug Administration (FDA) authorized Phase 3 pivotal clinical trials in the United States and across the globe by GW Pharmaceuticals.
Not exact matches
Researchers also noted that little is known about the
efficacy and safety of off - label use of naloxone for treating overdoses related to newly
emerging illicit uses of more powerful opioids such as fentanyl
and fentanyl derivatives.
Their research focused on evaluating the
safety and efficacy of autologous bone marrow - derived stem cell transplantation in individuals with type 2 diabetes with good glycemic control as well, which
emerged as an important aspect in the transplantation group as well as in the non-transplanted group.